tiprankstipranks
Tryptamine Therapeutics Limited (AU:TYP)
ASX:TYP
Australian Market
Holding AU:TYP?
Track your performance easily

Tryptamine Therapeutics (TYP) Technical Analysis

10 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Tryptamine Therapeutics Limited’s (TYP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Tryptamine Therapeutics Limited is a Buy.
Tryptamine Therapeutics Limited’s (TYP) 20-Day exponential moving average is 0.04, while Tryptamine Therapeutics Limited’s (TYP) share price is <AU$0.1, making it a Buy.
Tryptamine Therapeutics Limited’s (TYP) 50-Day exponential moving average is 0.04, while Tryptamine Therapeutics Limited’s (TYP) share price is <AU$0.1, making it a Buy.

Tryptamine Therapeutics (TYP) Pivot Points

Jan 19, 2025, 09:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Fibonacci
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tryptamine Therapeutics (TYP) Moving Averages

Jan 19, 2025, 09:19 AM
Period
Simple
Exponential
MA5
0.04Sell
0.04Buy
MA10
0.04Buy
0.04Buy
MA20
0.04Buy
0.04Buy
MA50
0.04Sell
0.04Buy
MA100
0.03Buy
0.03Buy
MA200
0.03Buy
0.03Buy
Tryptamine Therapeutics Limited’s (TYP) 10-Day exponential moving average is 0.04, while Tryptamine Therapeutics Limited’s (TYP) share price is <AU$0.1, making it a Buy.
Tryptamine Therapeutics Limited’s (TYP) 100-Day exponential moving average is 0.03, while Tryptamine Therapeutics Limited’s (TYP) share price is <AU$0.1, making it a Buy.
Tryptamine Therapeutics Limited’s (TYP) stock price is <AU$0.1 and Tryptamine Therapeutics Limited’s (TYP) 50-day simple moving average is 0.04, creating a Sell signal.
Tryptamine Therapeutics Limited’s (TYP) stock price is <AU$0.1 and Tryptamine Therapeutics Limited’s (TYP) 100-day simple moving average is 0.03, creating a Buy signal.
Tryptamine Therapeutics Limited’s (TYP) stock price is <AU$0.1 and Tryptamine Therapeutics Limited’s (TYP) 200-day simple moving average is 0.03, creating a Buy signal.

Tryptamine Therapeutics (TYP) Technical Indicators

Jan 19, 2025, 09:19 AM
Name
Value
Implied Action
RSI (14)
51.85
Neutral
STOCH (9,6)
74.60
Neutral
STOCHRSI (14)
44.44
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
-
Williams %R
-55.56
Buy
CCI (14)
13.61
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
87.13
Buy
ROC
0.00
Buy
Tryptamine Therapeutics Limited’s (TYP) Relative Strength Index (RSI) is 51.85, creating a Neutral signal.
Tryptamine Therapeutics Limited’s (TYP) Commodity Channel Index (CCI) is 13.61, creating a Neutral signal.

FAQ

Is TYP a Buy, Hold, or Sell?
Based on TYP’s technical indicators, TYP is a Buy.
    What is TYP’s RSI (14)?
    TYP’s RSI (14) is 51.85, which suggests TYP is a Neutral.
      What is TYP’s MACD?
      TYP’s MACD is <0.01, which suggests TYP is a Buy.
        What is TYP’s 5-day moving average?
        TYP’s 5-day moving average is 0.04, which suggests TYP is a Sell.
          What is TYP’s 20-day moving average?
          TYP 20-day moving average is 0.04, which suggests TYP is a Buy.
            What is TYP’s 50-day moving average?
            TYP’s 50-day moving average is 0.04, which suggests TYP is a Sell.
              What is TYP’s 200-day moving average?
              TYP’s 200-day moving average is 0.03, which suggests TYP is a Buy.
                What is TYP’s Williams % R (14)?
                TYP’s Williams % R (14) is -55.56, which suggests TYP is a Buy.
                  What is TYP’s CCI (14)?
                  TYP’s CCI (14) is 13.61, which suggests TYP is a Neutral.
                    What is the share price of Tryptamine Therapeutics Limited?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis